National Institutes of Health Clinical Center (CC)

nih.gov

Total trials

368

Capped at 5,000

Active

33

Phase 3

7

Total enrollment

30,819,078

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 11 of 11 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
filgrastim8
Dexamethasone2
Endotoxin2
Mycophenolate Mofetil1
Tacrolimus1
Post-Transplant Cyclophosphamide1
Briquilimab1
Spironolactone1
cyclophosphamide14
Fludarabine3
rDEN3Δ30/31-71641

Next readouts

  • 2025-04-23
  • 2025-10-16
  • 2026-12-31
  • 2027-06-30
  • 2032-01-01

Top conditions

  • Healthy33
  • Unspecified Adult Solid Tumor, Protocol Specific20
  • Lymphoma17
  • Liver Cancer13
  • Melanoma (Skin)12
  • Breast Cancer12
  • Healthy Volunteers11
  • Cerebral Palsy10

Frequently asked questions about National Institutes of Health Clinical Center (CC)

How many clinical trials does National Institutes of Health Clinical Center (CC) have on ClinicalTrials.gov?
National Institutes of Health Clinical Center (CC) is listed as the lead sponsor on 368 clinical trials in ClinicalTrials.gov, 33 of which are currently active (recruiting, enrolling, or ongoing).
How many of National Institutes of Health Clinical Center (CC)'s trials are in Phase 3?
7 of National Institutes of Health Clinical Center (CC)'s trials are in Phase 3, spread across 11 active drug programs.
What therapeutic areas does National Institutes of Health Clinical Center (CC) focus on?
National Institutes of Health Clinical Center (CC)'s most-studied conditions on ClinicalTrials.gov are Healthy, Unspecified Adult Solid Tumor, Protocol Specific, Lymphoma, Liver Cancer, Melanoma (Skin).
When are National Institutes of Health Clinical Center (CC)'s next clinical trial readouts?
National Institutes of Health Clinical Center (CC) has 5 upcoming primary-completion readouts tracked here; the soonest is “Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine”, expected around 2025-04-23.